Posts With Tag NLS Pharmaceutics Ltd

NLS Pharmaceutics Ltd. announces an Extraordinary Shareholders’ Meeting on Jan 14, 2025. Key details on voting rights and report filings included.

Explore NLS Pharmaceutics Ltd.'s December 2024 Form 6-K report, detailing the upcoming extraordinary shareholder meeting on January 7, 2025, and SEC compliance.